Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-12-02
1993-11-16
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
4241951, A61K 3121, A61K 3578
Patent
active
052624218
ABSTRACT:
A method for the treatment of hypertension, arrhythmia, thrombosis or/and atherosclerosis with an effective amount of dicentrine or other alkaloids extracted from Lindera oldhammii (megaphylla) Hemsl.
REFERENCES:
patent: 4543256 (1985-09-01), Neumeyer
Che-Ming Teng . . . "Dicentrine . . . from Lindera" Br. J. Pharmacol. 104(3):651-656 Oct. 1991.
Kondo et al. "Suppression of tumor cell . . . by . . . dicentrine" Biological Abs. 90(12): 137154 1990.
Kato et al ". . . crude extract of Linderae . . . on . . . cardiovascular system" Biological Abs. 76(2):12861 (1982).
Lu et al. "Studies . . Alkaloids Lindera" Yakugaku Zasshi 92(7) 910-917 (1972).
Chen Chien-Chih
Su Ming-Jai
Teng Che-Ming
Yu Sheu-Meei
Hook Gregory
National Science Council
Waddell Frederick E.
LandOfFree
Use of dicentrine and its derivatives for the treatment of hyper does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of dicentrine and its derivatives for the treatment of hyper, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of dicentrine and its derivatives for the treatment of hyper will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-22806